سعر فورتيو (20مكجم/80مل ) قلم 2.4 مل 2024

Teriparatide 20 mcg/80 microlitres solution for subcutaneous injection in a 2.4 ml pre-filled pen, by Eli Lilly; recombinant parathyroid hormone (1-34) analogue for osteoporosis.

• Treatment of postmenopausal women with osteoporosis at high risk for fracture.Population: Postmenopausal womenDailyMed (U.S. National Library of Medicine)
• Increase of bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture.Population: Adult menDailyMed (U.S. National Library of Medicine)
• Treatment of glucocorticoid-induced osteoporosis at high risk for fracture.Population: Adult men and womenDailyMed (U.S. National Library of Medicine)

• Most common: arthralgia, pain, nausea, rhinitis, dizziness, headache, hypertension, asthenia and leg cramps; transient hypercalcaemia in about 11% of women.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Serious hypersensitivity to teriparatide or any excipient.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Osteosarcoma (seen in rats): avoid in patients at increased risk - open epiphyses, Paget's disease of bone or unexplained alkaline phosphatase elevation, bone metastases or skeletal malignancy, prior external-beam or implant radiation involving the skeleton, hereditary disorders predisposing to osteosarcoma.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• May cause hypercalcaemia and cutaneous calcification/calciphylaxis; avoid in pre-existing hypercalcaemia; may worsen urolithiasis.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Transient orthostatic hypotension, usually within 4 hours of dosing; may predispose to digoxin toxicity through hypercalcaemia.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• DigoxinHypercalcaemia may predispose to digitalis toxicity; use with caution.DailyMed (U.S. National Library of Medicine)

• No human data to establish drug-associated risk; consider discontinuing when pregnancy is recognised.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Breastfeeding is not recommended during treatment because of the potential for serious adverse reactions in the infant.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Teriparatide: Recombinant human parathyroid hormone (1-34) analogue; once-daily intermittent administration stimulates new bone formation by preferential osteoblast activity over osteoclast activity.